Skip to content

Clinical Study Into the Cosmetic Results of Leukosan Adhesive

Clinical Study Into the Cosmetic Results of Leukosan Adhesive vs. Transcutaneous Wound Suture With Laparoscopic Trocar Incision

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02179723
Enrollment
77
Registered
2014-07-02
Start date
2012-03-31
Completion date
2013-07-31
Last updated
2014-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Healing Cosmetic Result

Keywords

wound healing, cosmetic results, trocar incision

Brief summary

This clinical study aims to assess whether the benefits of using Leukosan Adhesive on trocar incisions are greater or equivalent to those provided by the standard therapy of transcutaneous sutures. In particular, it tests the long-term cosmetic result after 3 months, the safety and tolerance, as well as the practicality of treatment with Leuksan Adhesive. An open, randomised, controlled, prospective, single location, clinical study of women of ages between 18 and 60 years within the time span of March 2013 and April 2013.

Detailed description

The medical devices compared were EU (European Union) approved market-ready products with relevant designation according to the legal requirements for medical devices and according to Council guideline 93/42/EWG dated 14th July. Leukosan Adhesive is a sterile, ultra high viscose adhesive for external skin closure. Due to the skin's moisture, this skin adhesive polymerizes within seconds into a flexible film firmly holding the edges of the wound together and protecting the wound itself. Premilene DSMP 24, 3/8 needle, thread 3/0 denier was used a a comparison. This suture material was the standard suture material used in the study centre.

Interventions

DEVICELeukosan Adhesive

Leukosan adhesive applied to one wound

DEVICETranscutaneous suture

Transcutaneous suture applied to one wound

Sponsors

Dr. Stephanie Krause
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Female between 18 and 60 * Undergone laparoscopic operation with 2 mirror image trocar incisions * Willing to attend examination at clinic at 7-12 days and 10-14 weeks * Signed agreement by participant

Exclusion criteria

* Length of laparoscopic operation more than 2 hours * Hospitalisation due to complications * Circumstances leading to difference in trocar incisions * Existing scar less than 3 cm from the operation point * Diabetic condition melitis HbA1c\>9mg/d * Known allergy to tissue adhesive * Participation in another study within 30 days

Design outcomes

Primary

MeasureTime frameDescription
Patient's satisfaction with cosmetic appearance/result of the wound3 months post operationThe primary outcome was the satisfaction of the patients with the cosmetic result of the wound healing after 3 months. This was measured by a visual analogue scale. In order to validate this result, an additional known wound assessment instrument, an ordinal scaled index, was implemented and the assessment of independent assessors was called on.

Secondary

MeasureTime frameDescription
The incidence of complication7-12 days post-operation7-12 days post-operation patients were examined for complications in treatment such as wound dehiscence, maceration, redness, overheating and pain
Intensity of pain7-12 days post-operation7-12 days post-operation patients were examined for intensity of pain
Investigator's assessment of cosmetic outcomeAt 3 months post-operationThe Investigator examined patients to assess the cosmetic outcome.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026